CDKN3

Yingjun Chen1, Dai Li2, Kaihui Sha3

  • 1Department of Infectious Diseases, Binzhou Medical University Hospital, Binzhou, 256600, Shandong, China.

概括

细胞周期蛋白依赖性激酶抑制蛋白3 (CDKN3) 在大多数癌症中是上调调节的,并且与患者的存活率有关. 准CDKN3可能会提供新的癌症治疗策略.